Global pharmaceutical company, Viatris, has announced additional details of its previously disclosed multi-year global restructuring initiative. The restructuring initiative is part of the company’s previously announced roadmap to maximize long-term value creation and is intended to ensure the new company is optimally structured to sustainably achieve its bold mission while also delivering on its financial […]
Tag: Rajiv Malik
Mylan, a global pharmaceutical company, announced an agreement to acquire the related intellectual property and commercialization rights of Aspen Pharmacare Holdings Limited’s thrombosis business in Europe for EUR 641.9 million, subject to customary closing conditions and European regulatory clearances. The transaction is expected to be immediately accretive to Mylan upon closing and is anticipated to […]